Home Vital Sentences Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Italian with Elisa (PDF)
Volume 1 | Volume 2

Free Abstracts

  Malignant Melanoma

  Free Subscription


3 Am J Dermatopathol
1 Cancer Res
1 Clin Cancer Res
1 Int J Cancer
1 J Immunol
1 J Invest Dermatol
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Dermatopathol

  1. JOUR G, Paniz-Mondolfi A, Reidy J, Cressey BD, et al
    Squamomelanocytic tumor: a case report and further insights into its possible histogenesis.
    Am J Dermatopathol. 2014;36:517-21.
    PubMed     Text format     Abstract available

  2. CHOY B, Chou S, Anforth R, Fernandez-Penas P, et al
    Panniculitis in Patients Treated With BRAF Inhibitors: A Case Series.
    Am J Dermatopathol. 2014;36:493-7.
    PubMed     Text format     Abstract available

  3. SETHI M, Craythorne E, Al-Arashi MY, Bhawan J, et al
    Macromelanosomes: their significantly greater presence in the margins of a lentigo maligna versus solar lentigo.
    Am J Dermatopathol. 2014;36:490-2.
    PubMed     Text format     Abstract available

    Cancer Res

  4. WEI F, Yang D, Tewary P, Li Y, et al
    The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant.
    Cancer Res. 2014;74:5989-98.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  5. GERAMI P, Cook RW, Wilkinson J, Russell MC, et al
    Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.
    Clin Cancer Res. 2015;21:175-83.
    PubMed     Text format     Abstract available

    Int J Cancer

  6. CHENG M, Ahmed M, Xu H, Cheung NK, et al
    Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy.
    Int J Cancer. 2015;136:476-86.
    PubMed     Text format     Abstract available

    J Immunol

  7. SPAAPEN RM, Leung MY, Fuertes MB, Kline JP, et al
    Therapeutic activity of high-dose intratumoral IFN-beta requires direct effect on the tumor vasculature.
    J Immunol. 2014;193:4254-60.
    PubMed     Text format     Abstract available

    J Invest Dermatol

  8. KHOSRAVI S, Tam KJ, Ardekani GS, Martinka M, et al
    eIF4E is an Adverse Prognostic Marker of Melanoma Patient Survival by Increasing Melanoma Cell Invasion.
    J Invest Dermatol. 2015 Jan 6. doi: 10.1038/jid.2014.
    PubMed     Text format     Abstract available

    PLoS One

  9. JIANG H, Clise-Dwyer K, Ruisaard KE, Fan X, et al
    Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model.
    PLoS One. 2014;9:e97407.
    PubMed     Text format     Abstract available

  10. SINGH S, Yang G, Schluns KS, Anthony SM, et al
    Sublingual Vaccination Induces Mucosal and Systemic Adaptive Immunity for Protection against Lung Tumor Challenge.
    PLoS One. 2014;9:e90001.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.